ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
673.02%
Change (1 year)
Categories
Market capitalization of ImmunoGen (IMGN)
Market cap: $8.72 Billion
As of April 2024 ImmunoGen has a market cap of $8.72 Billion. This makes ImmunoGen the world's 1770th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImmunoGen from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $8.72 B | 9.93% |
| 2023 | $7.93 B | 624.81% |
| 2022 | $1.09 B | -32.96% |
| 2021 | $1.63 B | 30.04% |
| 2020 | $1.25 B | 63.86% |
| 2019 | $0.76 B | 6.88% |
| 2018 | $0.71 B | -15.41% |
| 2017 | $0.84 B | 376% |
| 2016 | $0.17 B | -84.92% |
| 2015 | $1.18 B | 124.94% |
| 2014 | $0.52 B | -58.2% |
| 2013 | $1.25 B | 17.03% |
| 2012 | $1.07 B | 21.27% |
| 2011 | $0.88 B | 40.52% |
| 2010 | $0.62 B | 39.84% |
| 2009 | $0.45 B | 106.73% |
| 2008 | $0.21 B | 22.39% |
| 2007 | $0.17 B | -15.67% |
| 2006 | $0.21 B | 0.18% |
| 2005 | $0.21 B | -41.61% |
| 2004 | $0.36 B | 76.06% |
| 2003 | $0.20 B | 56.69% |
| 2002 | $0.13 B | -80.16% |
| 2001 | $0.65 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of ImmunoGen was reported to be:
$8.31 Billion
$8.72 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $353.68 B | 3,954.04% | 🇺🇸 USA |
 Novartis NVS | $200.85 B | 2,202.30% | 🇨🇭 Switzerland |
 Pfizer PFE | $145.38 B | 1,566.46% | 🇺🇸 USA |
 Eli Lilly LLY | $689.05 B | 7,798.22% | 🇺🇸 USA |
 Amgen AMGN | $143.76 B | 1,547.91% | 🇺🇸 USA |
 Sanofi SNY | $125.53 B | 1,338.87% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $91.75 B | 951.69% | 🇺🇸 USA |
 Seagen
SGEN | $43.15 B | 394.65% | 🇺🇸 USA |